Resources

/Resources
Resources 2020-02-04T03:58:50-05:00

RESOURCES

Browse our Resources

Use the below filters and search to find publications including Amicus Briefs, Testimony and Comments, IPO Law Journal Articles, and the IPO Federal Circuit Summaries™.

TITLE PUBLISHED CATEGORY
FEDERAL CIRCUIT REVERSES IPR DECISION CANCELING CLAIMS AS OBVIOUS BASED ON NON-ENABLED REFERENCE* * Raytheon Techs. Corp. V. General Electric Co., 20-1755 April 16, 2021 IPO Federal Circuit Summaries
NO STANDING FOR IPR APPEAL AFTER LITIGATION ON CHALLENGED PATENT WAS SETTLED* * Apple Inc. v. Qualcomm Incorporated, 20-1561 April 07, 2021 IPO Federal Circuit Summaries
EVIDENCE SUBMITTED TO PROVE INFRINGEMENT WAS INADMISSIBLE* Wi-LAN Inc. v. Sharp Elecs. Corp., 20-1041 April 06, 2021 IPO Federal Circuit Summaries
Protecting Software Related To a Medical Device: A Case Law Review and Strategy Guide April 05, 2021 IPO Law Journal
IPO Submits Comments to CNIPA on Draft Measures for Administrative Adjudication of Major Patent Disputes April 02, 2021 Testimony and Comments
IPO Statement on Values and Equality in Response to Death of George Floyd March 31, 2021 Testimony and Comments
IPO Statement on Discrimination Against the Asian/Pacific Islander Community March 31, 2021 Testimony and Comments
IPOwners Quarterly 03/31/2021 March 31, 2021 IPOwners Quarterly
Joint IP Associations Letter Supporting U.S. Opposition to TRIPS Waiver March 30, 2021 Testimony and Comments
USPTO CORRECTLY REJECTED PATENT CLAIMS AS PATENT-INELIGIBLE* In re The Board Of Trustees, 20-1288 March 25, 2021 IPO Federal Circuit Summaries
35 USC 101 Subject Matter Eligibility Cases – 2020 Update (Excel) March 12, 2021 IPO Law Journal
DISTRICT COURT DID NOT ERR IN UNSEALING AMENDED COMPLAINT THAT REVEALED IDENTITY OF MANUFACTURER JOINED AS DEFENDANT* DePuy Synthes Prods., Inc. v. Veterinary Orthopedic Implants, Inc., 20-1514 March 12, 2021 IPO Federal Circuit Summaries
USPTO DIRECTOR’S EXERCISE OF DISCRETION TO DENY INSTITUTION OF IPR IS UNREVIEWABLE* * * Mylan Labs. Ltd. v. Janssen Pharm., N.V., 21-1071 March 12, 2021 IPO Federal Circuit Summaries
USPTO CORRECTLY REJECTED PATENT CLAIMS AS PATENT-INELIGIBLE* In re The Board of Trustees, 20-1012 March 11, 2021 IPO Federal Circuit Summaries
DISTRICT COURT INCORRECTLY APPLIED DOCTRINE OF CLAIM VITIATION* Edgewell Personal Care Brands v. Munchkin, Inc., 20-1203 March 09, 2021 IPO Federal Circuit Summaries
PETITIONER JOINED TO IPR WAS NOT ESTOPPED FROM CHALLENGING CLAIMS UNDER § 315(e)(1) AS RPI OR PRIVY* * Uniloc 2017 LLC v. Facebook Inc., 19-1688 March 09, 2021 IPO Federal Circuit Summaries
IPO Letter to Senate Supporting IDEA Act March 08, 2021 Testimony and Comments
IPO Letter to House of Representatives Supporting IDEA Act March 08, 2021 Testimony and Comments
IPO Response to Question from USTR re: USTR’s Special 301 Review March 05, 2021 Testimony and Comments
IPO Comments on Discussion Draft of Digital Copyright Act of 2021 March 05, 2021 Testimony and Comments
U.S. GOVERNMENT DID NOT BREACH TRADEMARK LICENSING AGREEMENT BY REFUSING TO APPROVE USE OF MARK ON CERTAIN PRODUCTS AND MARKETING MATERIALS* Authentic Apparel Group, LLC v. United States, 20-1412 March 04, 2021 IPO Federal Circuit Summaries
IPO Letter to Senate and House IP Subcommittee Leaders on Key IP Issues March 04, 2021 Testimony and Comments
FEDERAL CIRCUIT FINDS MEANS-PLUS-FUNCTION CLAIM INDEFINITE BECAUSE GENERAL PURPOSE COMPUTER PROVIDED INSUFFICIENT STRUCTURE* * Rain Computing, Inc. v. Samsung Electronics Co., Ltd., 20-1646 March 02, 2021 IPO Federal Circuit Summaries
IPO Amicus Brief in Minerva Surgical, Inc. v. Hologic, Inc., et al. March 01, 2021 Amicus Briefs
FEDERAL CIRCUIT UPHOLDS DISTRICT COURT’S AWARD OF ATTORNEYS’ FEES* Arunachalam v. IBM, 20-1493 March 01, 2021 IPO Federal Circuit Summaries
SUBSTANTIAL EVIDENCE SUPPORTED JURY’S VERDICT FINDING INFRINGEMENT* Bayer HealthCare LLC v. Baxalta Inc., 19-2418 March 01, 2021 IPO Federal Circuit Summaries
U.S. INFRINGED SOFTWARE COPYRIGHT BY FAILING TO LIMIT NUMBER OF SIMULTANEOUS USERS* * Bitmanagement Software GMBH v. United States, 20-1139 February 25, 2021 IPO Federal Circuit Summaries
IPO Comments to USPTO re: National Strategy for Expanding American Innovation February 23, 2021 Testimony and Comments
ISSUE PRECLUSION BARRED REEXAMINATION DECISION CANCELING CLAIMS AS OBVIOUS* SynQor, Inc. v. Vicor Corp., 19-1704 February 22, 2021 IPO Federal Circuit Summaries
FEDERAL CIRCUIT UPHOLDS GRANT OF EQUITABLE INTERVENING PATENT RIGHTS* John Bean Techs. Corp. v. Morris & Associates, Inc., 20-1090 February 19, 2021 IPO Federal Circuit Summaries
USPTO ERRED IN OBVIOUSNESS ANALYSIS* Canfield Scientific, Inc. v. Melanoscan, LLC, 19-1927 February 18, 2021 IPO Federal Circuit Summaries
CLAIMS THAT CONTAINED AN IMPOSSIBILITY WERE INDEFINITE* Synchronoss Techs., Inc. v. Dropbox, Inc., 19-2196 February 12, 2021 IPO Federal Circuit Summaries
MOTION TO SUBSTITUTE AS SUCCESSOR-IN-INTEREST GRANTED* Mojave Desert Holdings, LLC v. Crocs, Inc., 20-1167 February 11, 2021 IPO Federal Circuit Summaries
CLAIMS INVALID DUE TO LACK OF ENABLEMENT* Amgen Inc. v. Sanofi, 20-1074 February 11, 2021 IPO Federal Circuit Summaries
COURT CORRECTLY HELD PATENT CLAIMS INVALID AS INDEFINITE* Infinity Computer Prods. v. Oki Data Americas, Inc., 20-1189 February 10, 2021 IPO Federal Circuit Summaries
USPTO PROPERLY DENIED PATENT TERM ADJUSTMENT WHERE NO PTAB DECISION ISSUED IN APPLICANT’S APPEALS BECAUSE EXAMINER REOPENED PROSECUTION* Chudik v. Hirshfeld, 20-1833 February 08, 2021 IPO Federal Circuit Summaries
CLAIMS RELATING TO LOYALTY PROGRAM REDEMPTIONS WERE PATENT-INELIGIBLE* cxLoyalty, Inc. v. Maritz Holdings Inc., 20-1307 February 08, 2021 IPO Federal Circuit Summaries
IPO Comments to USPTO re: Article of Manufacture Requirement February 04, 2021 Testimony and Comments
COURT REJECTS IPR DECISION THAT CLAIM WAS ANTICIPATED WHERE PETITION ASSERTED ONLY OBVIOUSNESS* M & K Holdings, Inc. v. Samsung Electronics Co., Ltd., 20-1160 February 01, 2021 IPO Federal Circuit Summaries
IPO 2021 Special 301 Review Comments January 28, 2021 Testimony and Comments
Load More